+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 12Years +
All Genders
ID07560618

Phase 4 Open-Label Study Evaluating Roflumilast 0.15% Cream for Itch and Skin Sensations in Atopic Dermatitis Patients

Led by Integrative Skin Science and Research · Updated on 2026-08-13

40

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with atopic dermatitis to better understand the different types of itching they experience and how these sensations change over time. This study focuses on people aged 12 years and older with mild to moderate atopic dermatitis and chronic itching for at least three months. The goal is to describe the skin sensations linked to atopic dermatitis and monitor changes over a 4-week period while using a specific topical cream. Participants will apply Roflumilast Cream 0.15% once daily to affected skin areas for four weeks. This open-label Phase 4 study involves a single group of participants receiving the active cream. The treatment is self-applied, and the study tracks changes in itch severity and skin condition throughout the treatment period. During the study, participants will complete daily questionnaires using a smartphone app to report their itching and skin sensations. Researchers will evaluate various measures including itch severity, eczema severity scores, body surface area affected, and quality of life related to skin health. The primary outcome is the number of descriptors used to describe skin sensations from enrollment to the end of treatment. The study includes safety monitoring and will last for approximately four weeks of treatment with assessments at baseline and study end.

CONDITIONS

Brief Title

Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Research Team

N

Nasima Afzal Chief Operating Officer

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here